These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 22926555)

  • 1. An NMR metabolomics approach for the diagnosis of leptomeningeal carcinomatosis.
    Cho HR; Wen H; Ryu YJ; An YJ; Kim HC; Moon WK; Han MH; Park S; Choi SH
    Cancer Res; 2012 Oct; 72(20):5179-87. PubMed ID: 22926555
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An NMR metabolomics approach for the diagnosis of leptomeningeal carcinomatosis in lung adenocarcinoma cancer patients.
    An YJ; Cho HR; Kim TM; Keam B; Kim JW; Wen H; Park CK; Lee SH; Im SA; Kim JE; Choi SH; Park S
    Int J Cancer; 2015 Jan; 136(1):162-71. PubMed ID: 24798643
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Leptomeningeal carcinomatosis: prognostic value of clinical, cerebrospinal fluid, and neuroimaging features.
    Palma JA; Fernandez-Torron R; Esteve-Belloch P; Fontes-Villalba A; Hernandez A; Fernandez-Hidalgo O; Gallego Perez-Larraya J; Martinez-Vila E
    Clin Neurol Neurosurg; 2013 Jan; 115(1):19-25. PubMed ID: 22534095
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Leptomeningeal carcinomatosis: prognostic implications of clinical and cerebrospinal fluid features.
    Bruna J; González L; Miró J; Velasco R; Gil M; Tortosa A;
    Cancer; 2009 Jan; 115(2):381-9. PubMed ID: 19109820
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Clinical analysis of leptomeningeal carcinomatosis in 4 cases].
    Bao J; Hu XQ; Jiang Y
    Nan Fang Yi Ke Da Xue Xue Bao; 2008 Nov; 28(11):2047-9. PubMed ID: 19033125
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diagnostic and prognostic significance of flow cytometry immunophenotyping in patients with leptomeningeal carcinomatosis.
    Subirá D; Simó M; Illán J; Serrano C; Castañón S; Gonzalo R; Granizo JJ; Martínez-García M; Navarro M; Pardo J; Bruna J
    Clin Exp Metastasis; 2015 Apr; 32(4):383-91. PubMed ID: 25795393
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cerebrospinal fluid cytology and clinical analysis of 34 cases with leptomeningeal carcinomatosis.
    Liu J; Jia H; Yang Y; Dai W; Su X; Zhao G
    J Int Med Res; 2009; 37(6):1913-20. PubMed ID: 20146891
    [TBL] [Abstract][Full Text] [Related]  

  • 8. NMR-based metabolomics analysis of leptomeningeal carcinomatosis.
    Jeon JP; Kim JE
    Neurosurgery; 2014 Oct; 75(4):N12-3. PubMed ID: 25232784
    [No Abstract]   [Full Text] [Related]  

  • 9. Diagnosis of leptomeningeal metastasis without a history of malignancy in the absence of cerebrospinal fluid abnormalities.
    Yokote A; Kawamoto T; Namioka T; Moteki Y; Kawamata T
    Clin Neurol Neurosurg; 2014 Apr; 119():88-90. PubMed ID: 24635933
    [No Abstract]   [Full Text] [Related]  

  • 10. Added Diagnostic Value of Cerebrospinal Fluid Carcinoembryonic Antigen in a Patient with Leptomeningeal Carcinomatosis as the Initial Manifestation of Gastric Cancer.
    Ino R; Sada KE; Miyauchi A; Hashimoto D; Nojima S; Yamanaka S; Kawamura M
    Acta Med Okayama; 2021; 75(5):659-661. PubMed ID: 34703051
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessment of compatibility between extraction methods for NMR- and LC/MS-based metabolomics.
    Beltran A; Suarez M; Rodríguez MA; Vinaixa M; Samino S; Arola L; Correig X; Yanes O
    Anal Chem; 2012 Jul; 84(14):5838-44. PubMed ID: 22697410
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Urine metabolite analysis as a function of deoxynivalenol exposure: an NMR-based metabolomics investigation.
    Hopton RP; Turner E; Burley VJ; Turner PC; Fisher J
    Food Addit Contam Part A Chem Anal Control Expo Risk Assess; 2010 Feb; 27(2):255-61. PubMed ID: 20013448
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of magnetic resonance imaging to detect neoplastic meningitis: limited use in leukemia and lymphoma but convincing results in solid tumors.
    Pauls S; Fischer AC; Brambs HJ; Fetscher S; Höche W; Bommer M
    Eur J Radiol; 2012 May; 81(5):974-8. PubMed ID: 21371841
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of flow cytometry immunophenotyping in the diagnosis of leptomeningeal carcinomatosis.
    Subirá D; Serrano C; Castañón S; Gonzalo R; Illán J; Pardo J; Martínez-García M; Millastre E; Aparisi F; Navarro M; Dómine M; Gil-Bazo I; Pérez Segura P; Gil M; Bruna J
    Neuro Oncol; 2012 Jan; 14(1):43-52. PubMed ID: 21993441
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metastatic squamous cell carcinoma in cerebrospinal fluid: why a rare diagnosis on cytology?
    Ren S; Huang Y; Shah P; Manucha V
    Acta Cytol; 2012; 56(2):209-13. PubMed ID: 22378087
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Known and emerging biomarkers of leptomeningeal metastasis and its response to treatment.
    Walbert T; Groves MD
    Future Oncol; 2010 Feb; 6(2):287-97. PubMed ID: 20146587
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Application of a 1H nuclear magnetic resonance (NMR) metabolomics approach combined with orthogonal projections to latent structure-discriminant analysis as an efficient tool for discriminating between Korean and Chinese herbal medicines.
    Kang J; Choi MY; Kang S; Kwon HN; Wen H; Lee CH; Park M; Wiklund S; Kim HJ; Kwon SW; Park S
    J Agric Food Chem; 2008 Dec; 56(24):11589-95. PubMed ID: 19053358
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Primary diffuse leptomeningeal gliomatosis: do we miss the diagnosis?
    Lepreux S; Sagnier S; Perez JT; Léger F; Sibon I; Vital A
    Clin Neuropathol; 2017; 36(5):222-226. PubMed ID: 28332472
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Equating, or correction for between-block effects with application to body fluid LC-MS and NMR metabolomics data sets.
    Draisma HH; Reijmers TH; van der Kloet F; Bobeldijk-Pastorova I; Spies-Faber E; Vogels JT; Meulman JJ; Boomsma DI; van der Greef J; Hankemeier T
    Anal Chem; 2010 Feb; 82(3):1039-46. PubMed ID: 20052990
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metabolic effects of dinoseb, diazinon and esfenvalerate in eyed eggs and alevins of Chinook salmon (Oncorhynchus tshawytscha) determined by 1H NMR metabolomics.
    Viant MR; Pincetich CA; Tjeerdema RS
    Aquat Toxicol; 2006 May; 77(4):359-71. PubMed ID: 16488491
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.